We are thrilled to receive an NCI R01 ($1.8M/5 years) and an ALSF R Award ($800K/4 years) to study the role of Pyruvate Kinase in both adult or pediatric T-ALL!

Thanks so much for your support!!

https://www.cinj.org/awards-totaling-26-million-support-exploration-therapeutic-strategy-adult-and-pediatric-t-cell